Author:
Kim Tae Hoon,Lee Dagyeong,Oh Hye Jeong,Ham In-Hye,Lee Dong Min,Lee Yulim,Zhang Zhang,Ke Ding,Hur Hoon
Funder
National Research Foundation of Korea
Institute for Basic Science
Ministry of Education
Ministry of Science, ICT and Future Planning
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference39 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018
2. Japanese gastric cancer treatment guidelines;Japanese Gastric Cancer A;Gastric Cancer,2018
3. Korean practice guidelines for gastric Cancer 2022: an evidence-based;Kim;Multidisciplinary Approach. J Gastric Cancer.,2023
4. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial;Bang;Lancet,2010
5. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial;Janjigian;Lancet,2021